News | May 24, 2024
Merck to showcase advances in the science of cancer with new data presented at ASCO 2024
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
Launch of 20 new medicines expected by 2030
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
The award recognizes powerful science–industry collaborations for social good
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Achira is engaged in development and commercialization of PoC medical test kits in India
Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
Subscribe To Our Newsletter & Stay Updated
